d**********r
发帖数: 24123 | 1 From Bloomberg today
FLML developing Micropump for single dose of Sodiul oxybate to traet
narcolepsy; Jazz Pharma's Xyrem uses two doses of sodium oxybate Patent
trail and appeal board yesterday issued decision denying covered business
method patent review for 4 Xyrem patents covering restricted distribution ,
JPMorgan analyst Jessica Fye said in note She sees as incremental poistive
for Jazz, removes potential threat to Xyrem franchise
是这个？ |
|
d**********r
发帖数: 24123 | 2 今天跌好像和老李说得这个有关
FA 这东西是生产一个手术后止疼麻醉的东东，目前美国市场是垄断地位！市场非常
需要，于是批准很多公司生产非法药物，而且医院可用。今年FDA批准了FLML 的，然后
命令其他药物全停止，查封。不过以前生产的可以用完，然后就只能用FLML的。FLML高
兴的屁似得，很多机构已经进住。
From Bloomberg today
FLML developing Micropump for single dose of Sodiul oxybate to traet
narcolepsy; Jazz Pharma's Xyrem uses two doses of sodium oxybate Patent
trail and appeal board yesterday issued decision denying covered business
method patent review for 4 Xyrem patents covering restricted distribution ,
JPMorgan analyst Jessica Fye sai... 阅读全帖 |
|
|
r*****g
发帖数: 7139 | 4 Committee votes 20-2 against recommending approval
* Drug contains "date rape" chemical
* Jazz shares halted during panel meeting
BETHESDA, Md., Aug 20 (Reuters) - A U.S. advisory panel on Friday rejected a
Jazz Pharmaceuticals Inc (JAZZ.O) medicine to treat the pain disorder
fibromyalgia amid concerns the product could be misused as a "date-rape"
drug.
A Food and Drug Administration advisory committee voted 20-2 against
recommending approval of sodium oxybate or JZP-6. The medicine contains a
f... 阅读全帖 |
|
